Shares of Moderna Inc.
MRNA,
-1.27%
slipped 1.27% to $173.15 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average
DJIA,
+0.01%
rising 0.01% to 33,852.53 and the NASDAQ Composite Index
COMP,
-0.59%
falling 0.59% to 10,983.78. This was the stock’s fourth consecutive day of losses. Moderna Inc. closed $184.49 short of its 52-week high ($357.64), which the company reached on November 30th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson
JNJ,
-0.70%
fell 0.70% to $176.09 and Pfizer Inc.
PFE,
-0.16%
fell 0.16% to $49.49. Trading volume (2.8 M) remained 2.0 million below its 50-day average volume of 4.8 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
